Abstract:Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as TGF-β and PDGFs), cytokines (including TNF-α, IL-1, IL-6, IL-10 and IL-4), and neurohumoral pathways trigger fibrogenic signaling cascades through binding to surface receptors, and activation of downstream signaling cascades. In addition, matricellular macromolecules are deposited in the remodeling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review manuscript discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction (HFrEF and HFpEF), genetic cardiomyopathies and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodeling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.

Cardiac Fibroblastic Niches in Homeostasis and Inflammation

Emerging Roles of Fibroblasts in Cardiovascular Calcification

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease

Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction

Role of Cardiac Fibroblasts in Cardiac Injury and Repair

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

Cardiac Fibrosis and Fibroblasts

Novel fibroblast phenotypes in homeostasis and chronic inflammation: From functions to potential regulators

Targeting immune-fibroblast cell communication in heart failure

Cardiac fibrosis.

View from the heart: cardiac fibroblasts in development, scarring and regeneration

Origins of cardiac fibroblasts

Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with myocardial infarction and other cardiovascular diseases

The inflammatory speech of fibroblasts

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling

Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development

Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling

Myofibroblasts and Fibrosis

Ca2+ Signaling in Cardiovascular Fibroblasts

Chromatin remodelling drives immune cell-fibroblast communication in heart failure

Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair